Last CNY24.85 CNY
Change Today 0.00 / 0.00%
Volume 0.0
002390 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 2:00 AM 02/13/15 All times are local (Market data is delayed by at least 15 minutes).

guizhou xinbang pharmaceut-a (002390) Snapshot

Open
CNY24.23
Previous Close
CNY24.85
Day High
CNY25.05
Day Low
CNY24.12
52 Week High
03/6/14 - CNY27.90
52 Week Low
07/24/14 - CNY16.70
Market Cap
12.4B
Average Volume 10 Days
2.4M
EPS TTM
CNY0.26
Shares Outstanding
500.5M
EX-Date
06/16/14
P/E TM
96.1x
Dividend
CNY0.03
Dividend Yield
0.12%
Current Stock Chart for GUIZHOU XINBANG PHARMACEUT-A (002390)

Related News

No related news articles were found.

guizhou xinbang pharmaceut-a (002390) Related Businessweek News

No Related Businessweek News Found

guizhou xinbang pharmaceut-a (002390) Details

Guizhou Xinbang Pharmaceutical Co., Ltd. is engaged in the research, development, manufacture, and distribution of Chinese patent medicines in China. The company provides medicines primarily for the treatment of cardio cerebral vascular diseases and digestive system diseases. It also offers urinary system medicines, anti-infective drugs, antipyretic analgesics, gynecological medication, calcium medication, anti-cold medication, and endocrine medicines. The company provides its products in tablet, capsule, and granule forms. Guizhou Xinbang Pharmaceutical Co., Ltd. was founded in 1995 and is based in Guiyang, China.

Founded in 1995

guizhou xinbang pharmaceut-a (002390) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

guizhou xinbang pharmaceut-a (002390) Key Developments

Guizhou Xinbang Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Feb 06, 2015

Guizhou Xinbang Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Feb 06, 2015., at 14:40 China Standard Time. Agenda: To approve guarantee for a subsidiary; to approve guarantee for controlled subsidiary; to approve guarantee for associated hospital by controlled subsidiaries; to approve guarantee for subordinate hospital by controlled subsidiaries; and to approve guarantee for wholly-owned subsidiaries.

Guizhou Xinbang Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Dec 25, 2014

Guizhou Xinbang Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Dec 25, 2014., at 14:40 China Standard Time. Agenda: To consider controlled subsidiary to provide financial aid to its subordinated hospital.

Guizhou Xinbang Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Oct 31, 2014

Guizhou Xinbang Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Oct 31, 2014., at 14:40 China Standard Time. Agenda: To consider the guarantee for controlled subsidiaries; to consider a controlled subsidiary to provide guarantee for its affiliated hospitals; to consider a controlled subsidiary to provide guarantee for its wholly-owned subsidiaries; to consider a controlled subsidiary to provide guarantee for its controlled subsidiaries; and to apply for comprehensive credit line to a bank.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002390:CH CNY24.85 CNY 0.00

002390 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002390.
View Industry Companies
 

Industry Analysis

002390

Industry Average

Valuation 002390 Industry Range
Price/Earnings 100.0x
Price/Sales 6.2x
Price/Book 4.6x
Price/Cash Flow 122.1x
TEV/Sales 5.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUIZHOU XINBANG PHARMACEUT-A, please visit www.xinbang.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.